Corvus Pharmaceuticals CRVS Market capitalization

Market capitalization at other companies

Eli LillyLLY

$1.07T+53.1%

Regeneron PharmaceuticalsREGN

$65.37B+15.9%

AbbVieABBV

$444.6B+35.6%

Aclaris TherapeuticsACRS

$738.82M+349%

Cullinan Therapeutics, Inc.CGEM

$1.12B+142%

Nektar TherapeuticsNKTR

$2.06B+1,531%

FAQ

What is Corvus Pharmaceuticals's market capitalization?

Corvus Pharmaceuticals (CRVS) reported market capitalization of $1.23B in Q1 2026.

How has Corvus Pharmaceuticals's market capitalization changed year-over-year?

Corvus Pharmaceuticals's market capitalization increased by 467.1% year-over-year, from $216.67M to $1.23B.

What is the long-term trend for Corvus Pharmaceuticals's market capitalization?

Over 5 years (2020 to 2025), Corvus Pharmaceuticals's market capitalization has grown at a 28.3% compound annual growth rate (CAGR), from $165.71M to $575.05M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.